Japan Approved Orladeyo for Under-Twelves in an Open-Label Interim Analysis of 29 Children
The molecule has been approved in Japan since 2021. What is new is a formulation a two-year-old can swallow, and that is the commercial move.
DealPulse Signal
The Beats
Analysis
The Briefs
Japan Approved Orladeyo for Under-Twelves in an Open-Label Interim Analysis of 29 Children
A Dual MYC and GSPT1 Degrader Extended Survival by Over 300% in One Preclinical Model
China Will Pay One Price for 158 Conditions, Whatever the Hospital
France Funded Two Cancer Drugs the Same Week. One Was Rated Therapeutic Progress, One Was Not.
Avulux Won a De Novo and Created the Category Its Competitors Will File Into